Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors

Clinical and Vaccine Immunology

Volumn 18, Issue 11, 2011, Pages 1969-1978

  Jackson, Shawn S ^a,b   Schmitz, Jörn E ^a   Letvin, Norman L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON ANTIBODY; GLYCOPROTEIN GP 140; IMMUNOGLOBULIN G; INTERLEUKIN 7 RECEPTOR ALPHA; RANTES; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VIRUS RECOMBINANT;

ADENOVIRIDAE; ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; CD8-POSITIVE T-LYMPHOCYTES; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; GENETIC VECTORS; HIV-1; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 80455179667     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05180-11     Document Type: Article

References (61)

1. Altman, J. D., et al. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96. (Pubitemid 26332731)
2. + T cells are programmed by prolonged antigen exposure and low levels of cellular activation. Eur. J. Immunol. 36:842-854.
3. + T cell response to Listeria monocytogenes in the absence of perforin and IFN-γ. J. Immunol. 164:6444-6452.
4. + T cell contraction is controlled by early inflammation. Nat. Immunol. 5:809-817.
5. + T cell homeostasis by perforin and interferon-gamma. Science 290:1354-1358.
6. Barouch, D. H., et al. 2004. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J. Immunol. 172:6290-6297. (Pubitemid 38621236)
7. Bell, J. J., et al. 2008. Early effector T cells producing significant IFN-γdevelop into memory. J. Immunol. 180:179-187.
8. Billiau, A., et al. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140:1506-1510.
9. Billiau, A., H. Heremans, F. Vandekerckhove, and C. Dillen. 1987. Antiinterferon- gamma antibody protects mice against the generalized Shwartzman reaction. Eur. J. Immunol. 17:1851-1854. (Pubitemid 18052056)
10. Billiau, A., H. Heremans, K. Vermeire, and P. Matthys. 1998. Immunomodulatory properties of interferon-gamma. An update. Ann. N. Y. Acad. Sci. 856:22-32.
11. Catanzaro, A. T., et al. 2006. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J. Infect. Dis. 194:1638-1649. (Pubitemid 44901994)
12. Cellerai, C., et al. 2010. Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7Rα (CD127) and perforin expression. J. Virol. 84:3868-3878.
13. Chawla-Sarkar, M., et al. 2003. Apoptosis and interferons: role of interferon- stimulated genes as mediators of apoptosis. Apoptosis 8:237-249. (Pubitemid 36749609)
14. Cheng, C., et al. 2010. Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. J. Virol. 84:630-638.
15. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244. (Pubitemid 18051419)
16. Chirmule, N., et al. 1999. Immune responses to adenovirus and adenoassociated virus in humans. Gene Ther. 6:1574-1583. (Pubitemid 29465516)
17. Debray-Sachs, M., et al. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN γ. J. Autoimmun. 4:237-248.
18. Espejo, C., et al. 2001. Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon- gamma receptor knockout mice. Exp. Neurol. 172:460-468. (Pubitemid 34075095)
19. Frucht, D. M., et al. 2001. IFN-γ production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 22:556-560. (Pubitemid 33016402)
20. Geiben-Lynn, R., J. R. Greenland, K. Frimpong-Boateng, and N. L. Letvin. 2008. Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia Ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses. Clin. Vaccine Immunol. 15:691-696. (Pubitemid 351967048)
21. Grau, G. E., et al. 1989. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. U. S. A. 86:5572-5574. (Pubitemid 19185586)
22. Greenland, J. R., et al. 2005. Beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization. Mol. Ther. 12:164-170. (Pubitemid 40862368)
23. Groettrup, M., S. Khan, K. Schwarz, and G. Schmidtke. 2001. Interferongamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 83:367-372. (Pubitemid 32293659)
24. + T cells responding to infection. J. Immunol. 174:6791-6802.
25. Haring, J. S., and J. T. Harty. 2006. Aberrant contraction of antigen-specific CD4 T cells after infection in the absence of gamma interferon or its receptor. Infect. Immun. 74:6252-6263. (Pubitemid 44657405)
26. + T cell response to infection. Curr. Opin. Immunol. 14:360-365.
27. Heremans, H., and A. Billiau. 1989. The potential role of interferons and interferon antagonists in inflammatory disease. Drugs 38:957-972. (Pubitemid 20017389)
28. Heremans, H., P. De Baetselier, and A. Billiau. 1990. Clinical potential of monoclonal antibodies against gamma interferon. Dev. Biol. Stand. 71:113-119. (Pubitemid 20197267)
29. Heremans, H., R. Dijkmans, H. Sobis, F. Vandekerckhove, and A. Billiau. 1987. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol. 138:4175-4179. (Pubitemid 17090383)
30. Heremans, H., C. Dillen, R. Dijkmans, G. Grau, and A. Billiau. 1989. The role of cytokines in various animal models of inflammation. Lymphokine Res. 8:329-333. (Pubitemid 19215543)
31. Heremans, H., C. Dillen, J. van Damme, and A. Billiau. 1994. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice. Eur. J. Immunol. 24:1155-1160. (Pubitemid 24132250)
32. Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau. 1990. Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171:1853-1869. (Pubitemid 20200228)
33. Hidalgo, L. G., J. Urmson, and P. F. Halloran. 2005. IFN-γ decreases CTL generation by limiting IL-2 production: a feedback loop controlling effector cell production. Am. J. Transplant. 5:651-661. (Pubitemid 40461274)
34. Huster, K. M., et al. 2004. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl. Acad. Sci. U. S. A. 101:5610-5615. (Pubitemid 38481204)
35. Jackson, S. S., et al. 2005. Evaluation of CD62L expression as a marker for vaccine-elicited memory cytotoxic T lymphocytes. Immunology 116:443-453. (Pubitemid 41713175)
36. Kaech, S. M., et al. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-1198. (Pubitemid 37540688)
37. Kuroda, M. J., et al. 1998. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187:1373-1381. (Pubitemid 28215397)
38. Lauvau, G., et al. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294:1735-1739. (Pubitemid 33104848)
39. Liu, J., et al. 2008. Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J. Virol. 82:4844-4852. (Pubitemid 351657046)
40. Lukacher, A. E. 2002. IFN-γ suspends the killing license of anti-tumor CTLs. J. Clin. Invest. 110:1407-1409. (Pubitemid 35396910)
41. Markine-Goriaynoff, D., et al. 2000. IFN-γ-independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 12:223-230. (Pubitemid 30088315)
42. Matthys, P., H. Heremans, G. Opdenakker, and A. Billiau. 1991. Antiinterferon- gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur. J. Cancer 27:182-187.
43. Matthys, P., T. Mitera, H. Heremans, J. Van Damme, and A. Billiau. 1995. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect. Immun. 63:1158-1164.
44. Peng, Y., E. Falck-Pedersen, and K. B. Elkon. 2001. Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation. J. Virol. 75:4540-4550. (Pubitemid 32381496)
45. Prlic, M., L. Lefrancois, and S. C. Jameson. 2002. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 195:F49-F52. (Pubitemid 34666064)
46. Qin, L., et al. 1997. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum. Gene Ther. 8:2019-2029. (Pubitemid 28072573)
47. Santra, S., et al. 2000. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses. J. Immunol. 165:6791-6795. (Pubitemid 32001145)
48. Shirai, M., et al. 1996. Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160. J. Immunol. 157:4399-4411. (Pubitemid 126449358)
49. Shiver, J. W., and E. A. Emini. 2004. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 55:355-372. (Pubitemid 38316732)
50. Sobek, V., S. Balkow, H. Korner, and M. M. Simon. 2002. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Eur. J. Immunol. 32:2490-2499.
51. + T cells. Microbes Infect. 5:227-231.
52. Sung, R. S., L. Qin, and J. S. Bromberg. 2001. TNF-α and IFN-γ induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol. Ther. 3:757-767. (Pubitemid 32509872)
53. Tewari, K., Y. Nakayama, and M. Suresh. 2007. Role of direct effects of IFN-γ on T cells in the regulation of CD8 T cell homeostasis. J. Immunol. 179:2115-2125.
54. Thorner, A. R., and D. H. Barouch. 2007. HIV-1 vaccine development: progress and prospects. Curr. Infect. Dis. Rep. 9:71-75. (Pubitemid 46242415)
55. Thorner, A. R., et al. 2006. Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa. J. Clin. Microbiol. 44:3781-3783. (Pubitemid 46768807)
56. Thornton, S., K. A. Kuhn, F. D. Finkelman, and R. Hirsch. 2001. NK cells secrete high levels of IFN-γ in response to in vivo administration of IL-2. Eur. J. Immunol. 31:3355-3360. (Pubitemid 33100528)
57. Torrico, F., et al. 1991. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:3626-3632.
58. - memory T cells do not differ in immediate effector cell function. J. Immunol. 169:638-641.
59. Uzonna, J. E., R. S. Kaushik, J. R. Gordon, and H. Tabel. 1998. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma; antibodies alters trypanosome-susceptible mice to a resistant-like phenotype. J. Immunol. 161:5507-5515. (Pubitemid 28519114)
60. Wherry, E. J., et al. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234. (Pubitemid 36322131)
61. Wu, X., et al. 2006. Novel function of IFN-γ: negative regulation of dendritic cell migration and T cell priming. J. Immunol. 177:934-943. (Pubitemid 44036594)